CN101721542A - Medicine for treating cardiovascular and cerebrovascular diseases - Google Patents

Medicine for treating cardiovascular and cerebrovascular diseases Download PDF

Info

Publication number
CN101721542A
CN101721542A CN200810230632A CN200810230632A CN101721542A CN 101721542 A CN101721542 A CN 101721542A CN 200810230632 A CN200810230632 A CN 200810230632A CN 200810230632 A CN200810230632 A CN 200810230632A CN 101721542 A CN101721542 A CN 101721542A
Authority
CN
China
Prior art keywords
parts
radix
medicine
blood
cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810230632A
Other languages
Chinese (zh)
Inventor
刘海松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810230632A priority Critical patent/CN101721542A/en
Publication of CN101721542A publication Critical patent/CN101721542A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating cardiovascular and cerebrovascular diseases, which contains the following natural crude drugs in parts by weight: 30-50 parts of angelica, 50-80 parts of cassia twig, 30-60 parts of Chinese ephedra, 10-30 parts of ginseng, 10-20 parts of prepared rehmannia root, 30-60 parts of weeping forsythia, 20-50 parts of figwort, 10-20 parts of twotooth achyranthes root, 10-50 parts of cinnamon and 30-50 parts of kapok. By taking the pharmacal theory of the traditional Chinese medicine of China as a basis and combining the clinical practice of many years, the medicine for treating the cardiovascular and cerebrovascular diseases is prepared by screening out and refining, from the medical repository of China, pure traditional Chinese medicines with the functions of clearing away heat and toxic materials, nourishing yin, removing heat from the blood, promoting blood circulation, removing blood stasis, warming the channel, dispelling cold, invigorating qi, nourishing the blood, recuperating depleted yang, invigorating pulse-beat and removing the necrotic tissue, has the functions of expanding the blood vessels, dissolving thrombus, promoting the blood circulation and changing the local blood supply state, purges involving tonification, treats without injuring the essential energy, tonifies without obstructing the middle-energy and can obviously enhance the immunity of organism.

Description

The medicine of treatment cardiovascular and cerebrovascular disease
One. technical field: the present invention relates to a kind of is the medicine of raw material with the natural Chinese medicine, particularly relates to a kind of medicine for the treatment of cardiovascular and cerebrovascular disease.
Two. background technology: cardiovascular and cerebrovascular disease is a kind of chronic general vascular disorder, pathological changes involve extremity in, small-sized arteriovenous is seen so that lower limb more more, motherland's medical science thinks that primary disease is sick mainly to be because feelings will internal injury admittedly, kidney liver deficiency, cold-damp is subjected to outward, so that cold-damp cohesion meridians, the numbness plug is obstructed, and vim and vigour running is not smooth, and lumen of vessels takes place inaccessible, the tube wall fibrosis, cause the local organization ischemia, last necrosis causes acral coming off, and cold stimulation is the key factor that primary disease takes place, extremity are the end of all sun, get yang-energy and temperature, the place is cold for a long time, and the cold-evil compels outward, yang-energy can not reach in limb end, cause the cold-evil to attack channels deeply, QI and blood is not smooth, and blood is met cold coagulation, it is obstructed to be retarded by silt, stagnation of QI and blood may bring about pain, with the passing of time, limbs are just become homeless foster, cause gangrene, thereby claim " necrosis disease " again; In addition, the generation of primary disease is also relevant with factors such as long-term smoking, wounds, and under the long-time stimulus of these factors, central nervous system's adjusting is hindered, the autonomic nerve system hormonal system functional disorder (as suprarenalism) of unifying, can make slow blood flow, medium and small continuous vessel spasm, blood vessel wall malnutrition, thrombosis and lumen of vessels obturation, local organization ischemia, necrosis, come off, secondary infection makes that the pain increased.
Three. summary of the invention:
The objective of the invention is: the medicine that a kind of advantages of simple of filling a prescription, clinical effectiveness treatment cardiovascular and cerebrovascular disease remarkable, with low cost is provided.
Technical scheme of the present invention is:
A kind of medicine for the treatment of cardiovascular and cerebrovascular disease, containing with the weight portion is the following natural material medicine of unit, 30~50 parts of Radix Angelicae Sinensis, 50~80 parts of Ramulus Cinnamomi, 30~60 parts in Herba Ephedrae, 10~30 parts of Radix Ginsengs, 10~20 parts in Radix Rehmanniae Preparata, 30~60 parts of Fructus Forsythiaes, 20~50 parts of Radix Scrophulariaes, 10~20 parts of Radix Achyranthis Bidentataes, 10~50 parts of Cortex Cinnamomis, 30~50 parts of kapoks.
The medicine of described treatment cardiovascular and cerebrovascular disease contains 35~45 parts of Radix Angelicae Sinensis, 50~70 parts of Ramulus Cinnamomi, 40~50 parts in Herba Ephedrae, 15~25 parts of Radix Ginsengs, 10~20 parts in Radix Rehmanniae Preparata, 35~45 parts of Fructus Forsythiaes, 30~40 parts of Radix Scrophulariaes, 10~20 parts of Radix Achyranthis Bidentataes, 20~30 parts of Cortex Cinnamomis, 40~50 parts of kapoks.
The medicine of described treatment cardiovascular and cerebrovascular disease contains 40 parts of Radix Angelicae Sinensis, 60 parts of Ramulus Cinnamomi, 45 parts in Herba Ephedrae, 15~25 parts of Radix Ginsengs, 10~20 parts in Radix Rehmanniae Preparata, 35~45 parts of Fructus Forsythiaes, 30~40 parts of Radix Scrophulariaes, 10~20 parts of Radix Achyranthis Bidentataes, 20~30 parts of Cortex Cinnamomis, 40~50 parts of kapoks.
With described Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing, remaining each component oven dry after grinding together, is crossed 100 mesh sieves, makes required pharmaceutical dosage form.
Described pharmaceutical dosage form is a powder, or is tablet, or is pill, or is granule, or is capsule.
Positive beneficial effect of the present invention is:
1. the medicine of treatment cardiovascular and cerebrovascular disease of the present invention, based on motherland's Chinese medicine and pharmacy theory, in conjunction with clinical practice for many years, from motherland medicine treasure-house, filter out have heat-clearing and toxic substances removing, YIN nourishing removing heat from blood, activating blood circulation and dissipating blood stasis, dispelling cold by warming the meridian, benefiting qi and nourishing blood, recuperating depleted YANG are promoted blood circulation, the pure purification of tcm of removing the necrotic tissue and promoting granulation forms, effect with blood vessel dilating, thrombus, blood circulation promoting, the local blood supply state of change, and residence is attacked in mending, attacking and just not to be hindered, to mend and do not stop up, and can obviously improve the immunity of human body.
2. the medicine of treatment cardiovascular and cerebrovascular disease of the present invention is a Chinese medicine preparation, need not decoct, can carry, and taking convenience, general patients with mild need not be in hospital, and can reduce patient's spending significantly, reduces medical expense.
3. the medicine of treatment cardiovascular and cerebrovascular disease of the present invention, prescription is reasonable, and cost is low, and processing is simple, and clinical efficacy is obvious, is applicable to the cardiovascular and cerebrovascular disease patient that each phase is dissimilar.
The medicine of treatment cardiovascular and cerebrovascular disease of the present invention, according to the mechanism of the traditional Chinese medical science " stagnation of QI is stasis then; the capable then blood of gas is capable, the capable then sick spontaneous recovery of blood ", reach the purpose of repercussive with benefiting vital QI and blood, " necrosis " patient again, the endogenous cause of ill heart, liver, spleen, kidney four is dirty all empty, and the exopathogenic factor cold-evil is strongly fragrant for a long time, accumulates and heat-transformation or surfeit greasy and surfeit flavour, pungently process rich and cause life fire-toxin in, if only use Radix Angelicae Sinensis, Ramulus Cinnamomi, the Radix Astragali, Radix Ginseng probably has impairment of YIN dryness-transformation anxiety, admittedly add Radix Rehmanniae Preparata, to make the scorching of the Ramulus Cinnamomi and the Radix Astragali, the kidney invigorating void again Kidney-Yin, monarch, minister, assistant, make and share, the effect of the dehumidifying of invigorating blood circulation is not only arranged, and detoxifcation arranged, removing heat from blood is fruit, the patient that it is applicable to cardiovascular and cerebrovascular disease patient, especially obstinate disease that each phase is dissimilar can cure without amputation, being subjected to patient's favorable comment deeply, is the medicine of present comparatively ideal treatment cardiovascular and cerebrovascular disease.
Four. the specific embodiment:
Embodiment one: a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, and containing with the weight portion is the following natural material medicine of unit: 30 parts of Radix Angelicae Sinensis, 50 parts of Ramulus Cinnamomi, 30 parts in Herba Ephedrae, 10 parts of Radix Ginsengs, 10 parts in Radix Rehmanniae Preparata, 30 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes, 10 parts of Cortex Cinnamomis, 30 parts of kapoks.Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing with described weight portion, remaining each component oven dry, after grinding together, cross 100 mesh sieves, make required pharmaceutical dosage form, one time 6~12 gram of patient, ante cibum warm boiled water, be a course of treatment at twice, 30 day every day, avoids suffering, peppery, greasy food and Folium Camelliae sinensis and tobacco and wine at period in a medicine.
Embodiment two: the preparation of present embodiment medicine and the method for taking are with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, 50 parts of Radix Angelicae Sinensis, 80 parts of Ramulus Cinnamomi, 60 parts in Herba Ephedrae, 30 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 60 parts of Fructus Forsythiaes, 50 parts of Radix Scrophulariaes, 20 parts of Radix Achyranthis Bidentataes, 50 parts of Cortex Cinnamomis, 50 parts of kapoks.
Embodiment three: the preparation of present embodiment medicine and the method for taking are with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, 41 parts of Radix Angelicae Sinensis, 60 parts of Ramulus Cinnamomi, 40 parts in Herba Ephedrae, 20 parts of Radix Ginsengs, 15 parts in Radix Rehmanniae Preparata, 450 parts of Fructus Forsythiaes, 30 parts of Radix Scrophulariaes, 15 parts of Radix Achyranthis Bidentataes, 40 parts of Cortex Cinnamomis, 40 parts of kapoks.
Embodiment four: a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, and containing with the weight portion is the following natural material medicine of unit: 30 parts of Radix Angelicae Sinensis, 50 parts of Ramulus Cinnamomi, 30 parts in Herba Ephedrae, 10 parts of Radix Ginsengs, 10 parts in Radix Rehmanniae Preparata, 30 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes, 10 parts of Cortex Cinnamomis, 30 parts of kapoks.Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing with described weight portion, remaining each component oven dry, after grinding together, cross 100 mesh sieves, make required pharmaceutical dosage form, one time 6~12 gram of patient, ante cibum warm boiled water, be a course of treatment at twice, 30 day every day, avoids suffering, peppery, greasy food and Folium Camelliae sinensis and tobacco and wine at period in a medicine.
Embodiment five: the preparation of present embodiment medicine and the method for taking are with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, 50 parts of Radix Angelicae Sinensis, 80 parts of Ramulus Cinnamomi, 60 parts in Herba Ephedrae, 30 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 60 parts of Fructus Forsythiaes, 50 parts of Radix Scrophulariaes, 20 parts of Radix Achyranthis Bidentataes, 50 parts of Cortex Cinnamomis, 50 parts of kapoks.
Embodiment six: the preparation of present embodiment medicine and the method for taking are with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, 41 parts of Radix Angelicae Sinensis, 60 parts of Ramulus Cinnamomi, 40 parts in Herba Ephedrae, 20 parts of Radix Ginsengs, 15 parts in Radix Rehmanniae Preparata, 450 parts of Fructus Forsythiaes, 30 parts of Radix Scrophulariaes, 15 parts of Radix Achyranthis Bidentataes, 40 parts of Cortex Cinnamomis, 40 parts of kapoks.

Claims (5)

1. medicine for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that: containing with the weight portion is the following natural material medicine of unit, 30~50 parts of Radix Angelicae Sinensis, 50~80 parts of Ramulus Cinnamomi, 30~60 parts in Herba Ephedrae, 10~30 parts of Radix Ginsengs, 10~20 parts in Radix Rehmanniae Preparata, 30~60 parts of Fructus Forsythiaes, 20~50 parts of Radix Scrophulariaes, 10~20 parts of Radix Achyranthis Bidentataes, 10~50 parts of Cortex Cinnamomis, 30~50 parts of kapoks.
2. the medicine of treatment cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: contain 35~45 parts of Radix Angelicae Sinensis, 50~70 parts of Ramulus Cinnamomi, 40~50 parts in Herba Ephedrae, 15~25 parts of Radix Ginsengs, 10~20 parts in Radix Rehmanniae Preparata, 35~45 parts of Fructus Forsythiaes, 30~40 parts of Radix Scrophulariaes, 10~20 parts of Radix Achyranthis Bidentataes, 20~30 parts of Cortex Cinnamomis, 40~50 parts of kapoks.
3. the medicine of treatment cardiovascular and cerebrovascular disease according to claim 2 is characterized in that: contain 40 parts of Radix Angelicae Sinensis, 60 parts of Ramulus Cinnamomi, 45 parts in Herba Ephedrae, 20 parts of Radix Ginsengs, 150 parts in Radix Rehmanniae Preparata, 40 parts of Fructus Forsythiaes, 35 parts of Radix Scrophulariaes, 15 parts of Radix Achyranthis Bidentataes, 25 parts of Cortex Cinnamomis, 45 parts of kapoks.
4. according to the medicine of the described treatment cardiovascular and cerebrovascular disease of the arbitrary claim of claim 1~3, it is characterized in that: with described Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing, remaining each component oven dry after grinding together, is crossed 100 mesh sieves, makes required pharmaceutical dosage form.
5. the medicine of treatment cardiovascular and cerebrovascular disease according to claim 4 is characterized in that: described pharmaceutical dosage form is a powder, or is tablet, or is pill, or is granule, or is capsule.
CN200810230632A 2008-10-29 2008-10-29 Medicine for treating cardiovascular and cerebrovascular diseases Pending CN101721542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810230632A CN101721542A (en) 2008-10-29 2008-10-29 Medicine for treating cardiovascular and cerebrovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810230632A CN101721542A (en) 2008-10-29 2008-10-29 Medicine for treating cardiovascular and cerebrovascular diseases

Publications (1)

Publication Number Publication Date
CN101721542A true CN101721542A (en) 2010-06-09

Family

ID=42443492

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810230632A Pending CN101721542A (en) 2008-10-29 2008-10-29 Medicine for treating cardiovascular and cerebrovascular diseases

Country Status (1)

Country Link
CN (1) CN101721542A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104587047A (en) * 2014-12-30 2015-05-06 史春雷 traditional Chinese medicine composition for treating cardiovascnlar and cerebrovascular diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104587047A (en) * 2014-12-30 2015-05-06 史春雷 traditional Chinese medicine composition for treating cardiovascnlar and cerebrovascular diseases
CN104587047B (en) * 2014-12-30 2018-04-27 青岛市中心医院 A kind of Chinese medicine composition for being used to treat cardiovascular and cerebrovascular disease

Similar Documents

Publication Publication Date Title
CN100571770C (en) A kind of Chinese medicine cutaneous permeable agent
CN103041136B (en) Chinese medicine preparation for treating hypertension
CN1299723C (en) Medicine for treating rhomboembolia type angiitis
CN102343008B (en) Chinese medicinal composition for treating prolapse of lumbar intervertebral disc
CN102178908B (en) Preparation method of traditional Chinese medicine for treating over fatigue cold injury
CN102641471B (en) Traditional Chinese medicine for treating cholelithiasis
CN102247504B (en) Method for preparing wart eliminating powder
CN102188679B (en) Method for preparing Chinese medicine for treating qi-blood infirmity frostbite
CN101700388A (en) Traditional Chinese medicine for treating trauma type cervical spondylosis
CN101721542A (en) Medicine for treating cardiovascular and cerebrovascular diseases
CN102178909A (en) Method for preparing traditional Chinese medicine for treating hypothermia type frostbite
CN101897924A (en) Chinese medicinal preparation for treating biliary calculus
CN102018815A (en) Chinese medicine preparation for treating tuberculosis of lumbar spine
CN104825650A (en) Nerves-soothing brain-strengthening oral liquid
CN104606511A (en) Traditional Chinese medicine for preventing postoperative bounce phenomenon after minimally invasive therapy on lubar intervertebral disc protrusion
CN102178883B (en) Preparation method of traditional Chinese medicine for treating hunger type frostbite
CN103070994B (en) Plaster for treating cervical and lumbar spondylosis
CN102526685A (en) Medicament for treating cervical spondylosis
CN105213865A (en) A kind of Chinese medicine composition for the treatment of coronary heart disease
CN105213985A (en) A kind of Chinese medicine decoction for the treatment of syndrome of marrow depletion due to kidney deficiency type cranial tinnitus
CN102836273B (en) Medicament for treating osteonecrosis
CN104162122A (en) Traditional Chinese medicine composition capable of treating hypotension
CN1218735C (en) Medicine composition for treating pain in waist and lower limbs and hyperosteogeny
CN102631653B (en) Method for preparing traditional Chinese medicine (TCM) lotion for treating spleen deficiency type pustule on sole
CN101450118A (en) Medicine for treating lumbar intervertebral disk hernia

Legal Events

Date Code Title Description
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Haisong

Document name: Notification of Passing Preliminary Examination of the Application for Invention

C06 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Liu Haisong

Document name: Notification of Publication of the Application for Invention

DD01 Delivery of document by public notice

Addressee: Liu Haisong

Document name: Notification of before Expiration of Request of Examination as to Substance

DD01 Delivery of document by public notice

Addressee: Liu Haisong

Document name: Notification that Application Deemed to be Withdrawn

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100609